-
Australasian Psychiatry : Bulletin of... Jun 2024To consider the contribution of non-clinical factors in the rising rate of mental health presentations and explore the associated silence within the psychiatric...
OBJECTIVE
To consider the contribution of non-clinical factors in the rising rate of mental health presentations and explore the associated silence within the psychiatric profession.
CONCLUSION
Medicalisation, concept creep and group think, alongside societal demand and expectations, have collectively contributed toward a distorted view of mental health and illness. Equitable service provision has been hindered by the silence of important perspectives.
Topics: Humans; Psychiatry; Mental Disorders; Mental Health Services; Medicalization
PubMed: 38444074
DOI: 10.1177/10398562241236317 -
Journal of Food and Drug Analysis Apr 2018The concept of Pharmacovigilance Planning and Risk Minimization Planning (PVP/RMP), initiated by the International Conference on Harmonization (ICH), addressed an... (Review)
Review
The concept of Pharmacovigilance Planning and Risk Minimization Planning (PVP/RMP), initiated by the International Conference on Harmonization (ICH), addressed an important conceptual change from monitoring the safety of individual medicine to proactively conducting risk prevention for the minimization of medication error. However, the implementation of PVP/RMP is a challenge in societies like Taiwan where irrational medication and co-medication is prevalent. It is even more difficult in Taiwan where two regulatory bodies are governing pharmaceutical affairs, namely Taiwan Food and Drug Administration (TFDA) in charge of Western Medicine (WM) and the Department of Chinese Medicine and Pharmacy (DCMP) in charge of Traditional Chinese Medicine (TCM). There are thus dual-tract drug approval panels, two GMP controls and two independent adverse drug event reporting systems. This rendered irrational co-medication of WM and TCM undetectable and the standard tools for monitoring pharmacovigilance inapplicable. The bilateral regulatory system is conceptually unscientific in accordance with PVP/RMP and unethical from humanity point of view. The first part of this review delivers (1) social aspects of polypharmacy in Taiwan; (2) regulatory aspects of pharmaceutical administration; (3) risks undermined in the bilateral regulatory system and (4) pharmacoepidemiology in relation to the risk of polypharmacy. As evidence-based medicine (EBM) forms the fundamental risk-benefit assessment on medication, the second part of this review delivers (1) the scientific aspects of the beauty and the odds of biological system that governs host-xenobiotics interaction; (2) conceptual evolution from product management (pharmacovigilance) to risk management (PVP/RMP); (3) non-biased due process is essential for risk-benefit assessment on medicinal products and (4) the opinion of the authors on system building for safe medication.
Topics: Drug and Narcotic Control; Humans; Legislation, Drug; Medicine, Chinese Traditional; Pharmaceutical Preparations; Pharmacovigilance; Risk Assessment; Taiwan
PubMed: 29703384
DOI: 10.1016/j.jfda.2017.11.012 -
Emergency Medicine Practice Feb 2018Thermal burn injuries are a significant cause of morbidity and mortality worldwide. In addition to treatment of the burns, emergency clinicians must assess for...
Thermal burn injuries are a significant cause of morbidity and mortality worldwide. In addition to treatment of the burns, emergency clinicians must assess for inhalation injury, exposure to toxic gases, and related traumatic injuries. Priorities for emergency resuscitation include stabilization of airway and breathing, intravenous fluid administration, pain control, and local wound care. Special populations, including children and pregnant women, require additional treatment considerations. Referral to specialized burn care for select patients is necessary to improve long-term outcomes. This article reviews thermal burn classification and evidence-based treatment strategies.
Topics: Burns; Disease Management; Emergency Service, Hospital; Fluid Therapy; Humans; Pain Management; Resuscitation
PubMed: 29369586
DOI: No ID Found -
BMC Medical Ethics Sep 2022Science and technology have vastly expanded the realm of medicine. The numbers of and knowledge about diseases has greatly increased, and we can help more people in many...
Science and technology have vastly expanded the realm of medicine. The numbers of and knowledge about diseases has greatly increased, and we can help more people in many more ways than ever before. At the same time, the extensive expansion has also augmented harms, professional responsibility, and ethical concerns. While these challenges have been studied from a wide range of perspectives, the problems prevail. This article adds value to previous analyses by identifying how the moral imperative of medicine has expanded in three ways: (1) from targeting experienced phenomena, such as pain and suffering, to non-experienced phenomena (paraclinical signs and indicators); (2) from addressing present pain to potential future suffering; and (3) from reducing negative wellbeing (pain and suffering) to promoting positive wellbeing. These expansions create and aggravate problems in medicine: medicalization, overdiagnosis, overtreatment, risk aversion, stigmatization, and healthism. Moreover, they threaten to infringe ethical principles, to distract attention and responsibility from other competent agents and institutions, to enhance the power and responsibility of professionals, and to change the professional-beneficiary relationship. In order to find ways to manage the moral expansion of medicine, four traditional ways of setting limits are analyzed and dismissed. However, basic asymmetries in ethics suggest that it is more justified to address people's negative wellbeing (pain and suffering) than their positive wellbeing. Moreover, differences in epistemology, indicate that it is less uncertain to address present pain and suffering than future wellbeing and happiness. Based on these insights the article concludes that the moral imperative of medicine has a gradient from pain and suffering to wellbeing and happiness, and from the present to the future. Hence, in general present pain and suffering have normative priority over future positive wellbeing.
Topics: Humans; Knowledge; Medicalization; Morals; Pain
PubMed: 36138414
DOI: 10.1186/s12910-022-00836-2 -
Clinical Medicine (London, England) Dec 2013The likelihood of a general physician encountering a patient with compensated and decompensated liver disease is increasing. This article provides an overview of... (Review)
Review
The likelihood of a general physician encountering a patient with compensated and decompensated liver disease is increasing. This article provides an overview of pharmaceutical agents currently used in the management of cirrhosis and is designed to allow a better understanding of the rationale for using certain drugs in patients with often complex pathology.
Topics: Disease Management; Humans; Liver Diseases; Pharmaceutical Preparations
PubMed: 24298107
DOI: 10.7861/clinmedicine.13-6-585 -
The International Journal of Health... 2010
Topics: Drug Industry; Health Workforce; Humans; Pharmaceutical Preparations; Policy Making
PubMed: 20191592
DOI: 10.1002/hpm.1043 -
Professional Case Management 2016With the changing landscape of health care delivery in the United States since the passage of the Patient Protection and Affordable Care Act in 2010, health care...
UNLABELLED
With the changing landscape of health care delivery in the United States since the passage of the Patient Protection and Affordable Care Act in 2010, health care organizations have struggled to keep pace with the evolving paradigm, particularly as it pertains to population health management. New nomenclature emerged to describe components of the new environment, and familiar words were put to use in an entirely different context.
PURPOSE/OBJECTIVES
This article proposes a working framework for activities performed in case management, disease management, care management, and care coordination. The author offers standard working definitions for some of the most frequently used words in the health care industry with the goal of increasing consistency for their use, especially in the backdrop of the Centers for Medicaid & Medicare Services offering a "chronic case management fee" to primary care providers for managing the sickest, high-cost Medicare patients.
PRIMARY PRACTICE SETTINGS
Health care organizations performing case management, care management, disease management, and care coordination.
FINDINGS/CONCLUSIONS
Road map for consistency among users, in reporting, comparison, and for success of care management/coordination programs.
IMPLICATIONS FOR CASE MANAGEMENT PRACTICE
This article offers a working framework for disease managers, case and care managers, and care coordinators. It suggests standard definitions to use for disease management, case management, care management, and care coordination. Moreover, the use of clear terminology will facilitate comparing, contrasting, and evaluating all care programs and increase consistency. The article can improve understanding of care program components and success factors, estimate program value and effectiveness, heighten awareness of consumer engagement tools, recognize current state and challenges for care programs, understand the role of health information technology solutions in care programs, and use information and knowledge gained to assess and improve care programs to design the "next generation" of programs.
Topics: Case Management; Delivery of Health Care; Disease Management; Humans; Managed Care Programs; Organization and Administration; Patient Care Management; Practice Guidelines as Topic; United States
PubMed: 27035084
DOI: 10.1097/NCM.0000000000000147 -
Mayo Clinic Proceedings Jun 2020
Topics: Betacoronavirus; COVID-19; Comorbidity; Coronavirus Infections; Health Services Accessibility; Health Services Needs and Demand; Humans; Medication Systems; Medication Therapy Management; Needs Assessment; Pandemics; Pharmaceutical Preparations; Pharmaceutical Services; Pneumonia, Viral; SARS-CoV-2; United States
PubMed: 32312491
DOI: 10.1016/j.mayocp.2020.04.001 -
Gaceta Medica de Mexico 2016
Topics: Delivery of Health Care; Humans; Medicalization
PubMed: 27335181
DOI: No ID Found -
Primary Care Jun 2012A significant portion of the adult population uses one or more medications on a regular basis to manage chronic conditions. As the number of medications that patients... (Review)
Review
A significant portion of the adult population uses one or more medications on a regular basis to manage chronic conditions. As the number of medications that patients are prescribed increases, an increase in pharmacologic-related issues and complications may occur, such as polypharmacy, inappropriate prescribing, medication nonadherence and nonpersistence, and adverse drug reactions and events. Risk factors and consequences of these issues have been identified and are discussed in this article. In addition, a review is presented of the numerous methods that have been evaluated to help prevent and minimize these pharmacologic issues in the management of chronic disease.
Topics: Algorithms; Chronic Disease; Disease Management; Drug-Related Side Effects and Adverse Reactions; Humans; Inappropriate Prescribing; Medication Adherence; Pharmaceutical Preparations; Polypharmacy; Practice Patterns, Physicians'; Prescription Drugs; Risk Factors
PubMed: 22608870
DOI: 10.1016/j.pop.2012.03.007